Market Cap : 38.36 B | Enterprise Value : 39.45 B | PE Ratio : 53.09 | PB Ratio : 3.53 |
---|
NAS:ILMN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ILMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ROE % is calculated as Net Income attributable to Common Stockholders (Net Income minus dividends to participating security holders) divided by its average Total Stockholders Equity over a certain period of time. Illumina's annualized net income attributable to common stockholders for the quarter that ended in Mar. 2022 was $344 Mil. Illumina's average Total Stockholders Equity over the quarter that ended in Mar. 2022 was $10,818 Mil. Therefore, Illumina's annualized ROE % for the quarter that ended in Mar. 2022 was 3.18%.
The historical rank and industry rank for Illumina's ROE % or its related term are showing as below:
During the past 13 years, Illumina's highest ROE % was 29.32%. The lowest was 8.27%. And the median was 23.02%.
The historical data trend for Illumina's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Illumina's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's ROE % distribution charts can be found below:
* The bar in red indicates where Illumina's ROE % falls into.
Illumina's annualized ROE % for the fiscal year that ended in Dec. 2021 is calculated as
ROE % | = | Net Income attributable to Common Stockholders (A: Dec. 2021 ) | / | ( (Total Stockholders Equity (A: Dec. 2020 ) | + | Total Stockholders Equity (A: Dec. 2021 )) | / count ) |
= | 762 | / | ( (4694 | + | 10740) | / 2 ) | |
= | 762 | / | 7717 | ||||
= | 9.87 % |
Illumina's annualized ROE % for the quarter that ended in Mar. 2022 is calculated as
ROE % | = | Net Income attributable to Common Stockholders (Q: Mar. 2022 ) | / | ( (Total Stockholders Equity (Q: Dec. 2021 ) | + | Total Stockholders Equity (Q: Mar. 2022 )) | / count ) |
= | 344 | / | ( (10740 | + | 10895) | / 2 ) | |
= | 344 | / | 10817.5 | ||||
= | 3.18 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income attributable to common stockholders of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income attributable to common stockholders data used here is four times the quarterly (Mar. 2022) net income attributable to common stockholders data. ROE % is displayed in the 30-year financial page.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
ROE %** | (Q: Mar. 2022 ) | ||||
= | Net Income | / | Total Stockholders Equity | ||
= | 344 | / | 10817.5 | ||
= | (Net Income / Revenue ) | * | (Revenue / Total Assets) | * | (Total Assets / Total Stockholders Equity) |
= | (344 / 4892) | * | (4892 / 15245.5) | * | (15245.5 / 10817.5) |
= | Net Margin % | * | Asset Turnover | * | Equity Multiplier |
= | 7.03 % | * | 0.3209 | * | 1.4093 |
= | ROA % | * | Equity Multiplier | ||
= | 2.26 % | * | 1.4093 | ||
= | 3.18 % |
With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.
The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:
ROE %** | (Q: Mar. 2022 ) | ||||||||
= | Net Income | / | Total Stockholders Equity | ||||||
= | 344 | / | 10817.5 | ||||||
= | (Net Income /Pre-Tax Income) | * | (Pre-Tax Income/Operating Income) | * | (Operating Income/Revenue) | * | (Revenue/Total Assets) | * | (Total Assets/Total Stockholders Equity) |
= | (344 / 560) | * | (560 / 736) | * | (736 / 4892) | * | (4892 / 15245.5) | * | (15245.5 / 10817.5) |
= | Tax Burden | * | Interest Burden | * | Operating Margin % | * | Asset Turnover | * | Equity Multiplier |
= | 0.6143 | * | 0.7609 | * | 15.04 % | * | 0.3209 | * | 1.4093 |
= | 3.18 % |
Note: The net income attributable to common stockholders data used here is four times the quarterly (Mar. 2022) net income attributable to common stockholders data. The Revenue data used here is four times the quarterly (Mar. 2022) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.
Net income attributable to common stockholders is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Thank you for viewing the detailed overview of Illumina's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Flatley Jay T | director | 9885 TOWNE CENTRE DR SAN DIEGO CA 92121 |
Tousi Susan H | officer: SVP Product Development | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Reeves Kathryne Gambrell | officer: SVP, Chief Marketing Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Goswami Joydeep | officer: SVP Corp Business Development | SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023 |
Dadswell Charles | officer: SVP & General Counsel | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Desouza Francis A | director, officer: President and CEO | 350 ELLIS STREET MOUNTAIN VIEW CA 94043 |
Van Oene Mark | officer: SVP Chief Commercial Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Ragusa Robert P | officer: SVP, Global Quality & Ops | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: RAGUSA ROBERT P a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Mcginnis Karen K | officer: VP, Chief Accounting Officer | INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284 |
Hoyt Aimee L | officer: SVP, Chief People Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Ronaghi Mostafa | officer: SVP, Entrepreneurial Devlopmt | 9885 TOWNE CENTRE DRIVE SAN DIEGO CA 92121 |
Aravanis Alexander | officer: SVP, Chief Technology Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Siegel Susan E | director | 3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025 |
Thompson John Wendell | director | C/O MICROSOFT CORPORATION ONE MICROSOFT WAY REDMOND WA 98053 |
Epstein Robert S | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: EPSTEIN ROBERT S a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
From GuruFocus
By PRNewswire 02-03-2022
By PRNewswire 02-21-2022
By PRNewswire 12-23-2021
Other Sources
By Zacks 2022-03-01
By Fool 2022-01-23
By Zacks 2022-02-18
By Zacks 2022-02-10
By Zacks 2022-01-12
By Zacks 2022-02-11
By Fool 2022-01-22
By Seekingalpha 2022-03-07
By Fool 2022-01-11
By Zacks 2022-03-18
By Zacks 2022-03-14
By Zacks 2022-02-09
By Zacks 2022-03-18
By Zacks 2022-01-13
By Zacks 2022-02-07